Community knowledge, chronic morbidity and microfilaraemia following mass drug administration for lymphatic filariasis in northern Ghana: a cross-sectional study
- 1WHO Country Office, Accra, Ghana
Abstract
ObjectivesTo assess microfilaraemia, chronic lymphatic filariasis (LF)-related morbidity, and community knowledge and self-reported preventive behaviours in a rural community in northern Ghana following prolonged mass drug administration (MDA).
DesignCommunity-based cross-sectional study.
SettingBirifor community, Lawra Municipality, Upper West Region, northern Ghana, from October 2024 to January 2025.
ParticipantsA total of 261 community members aged 10 years and above were selected using random sampling and participated in the study.
Outcome measuresOutcome measures included microfilaraemia detected by night blood microscopy, chronic LF-related morbidity identified through clinical examination, and community knowledge and self-reported preventive behaviours assessed using a structured questionnaire.
ResultsNo microfilariae were detected (0/261; 0%). Chronic lymphoedema was identified in five individuals (1.9%), all aged over 40 years. Awareness of LF was high (95.8%), yet only 39.5% of participants demonstrated good community knowledge and self-reported preventive behaviours. Misconceptions regarding transmission, particularly beliefs that LF is hereditary or caused by spiritual factors, were common. MDA participation was high (93.1%). All five individuals with chronic lymphoedema reported loss of income, and three (60%) reported additional household income loss due to caregiving responsibilities.
ConclusionsNo microfilaraemia was detected, suggesting very low transmission in the study area, although residual infection cannot be excluded. Chronic LF-related morbidity and gaps in community knowledge persist despite high MDA participation. Sustained surveillance using more sensitive diagnostic approaches, together with morbidity management and disability prevention, community education and support for affected households, will be important to sustain LF elimination efforts.
Article SummaryThis community-based cross-sectional study assessed microfilaraemia, chronic lymphatic filariasis-related morbidity, and community knowledge and self-reported preventive behaviours in a rural community in northern Ghana following prolonged mass drug administration. No microfilariae were detected, suggesting very low transmission, although residual infection could not be excluded. Chronic lymphoedema persisted among a small number of older community members, and important misconceptions regarding disease transmission and prevention remained common despite high awareness and MDA participation. These findings highlight the need for continued surveillance, strengthened morbidity management and disability prevention services, and targeted community education to sustain lymphatic filariasis elimination efforts.
Strengths and limitations of this studyO_LIThis study combined parasitological assessment, clinical evaluation of chronic lymphatic filariasis-related morbidity, and assessment of community knowledge and self-reported preventive behaviours within a single community-based survey. C_LIO_LIThe study was conducted in a post-mass drug administration setting, providing evidence relevant to lymphatic filariasis elimination and post-elimination surveillance programmes. C_LIO_LIUse of a participant flow diagram and complete-data analysis improved transparency and reporting of participant recruitment and inclusion. C_LIO_LIThe sample size was below the calculated minimum required for prevalence estimation, limiting the precision of prevalence estimates and the statistical power for multivariable analyses. C_LIO_LIParasitological assessment relied on night blood microscopy because circulating filarial antigen detection and molecular diagnostic methods were not available during fieldwork, limiting detection of low-level residual infection. C_LI
Related
- Population pharmacokinetics modeling of albendazole and its active metabolite, albendazole sulfoxide in mass drug administration against lymphatic filariasis
- Evaluating the cost of self-care: Impact of enhanced morbidity management protocol on people living with lymphatic filariasis in Bangladesh
- Pre-TAS Evaluation of mass drug administration effectiveness on lymphatic filariasis elimination and study of Immunological response in elephantiasis patients in Osun State, Nigeria
- Co-designing the ‘LEAD’ strategy: A theory-informed stakeholder-led behavioural intervention to improve mass drug administration compliance for lymphatic filariasis elimination in an urban block of Odisha, India
- A cross-sectional study of patients’ morbidity profiles and doctors’ drug prescribing patterns from outpatient departments of a community health centre from a district of Uttarakhand
BibTeX
@misc{ngmembong2026community,
title = {{Community knowledge, chronic morbidity and microfilaraemia following mass drug administration for lymphatic filariasis in northern Ghana: a cross-sectional study}},
author = {C. N. Ngmembong and M. Captain-Esoah and S. Lareef and E. D. Angyiereyiri and M. N. Donkor and S. D. Dassah and M. K. Azameti and G. A. Motey and L. A. Adetunde and T. A. Abalori and K. K. Frempong and C. Kubio and V. Asoala and D. A. Boakye and S. K. Dadzie and F. O. Antwi and M. R. Adjei and M. P. Grobusch and D. Bakajika and F. J. Lule and E. Juma and F. Braka and D. Achu},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.07.26364534},
url = {https://www.medrxiv.org/content/10.64898/2026.10.07.26364534v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Community knowledge, chronic morbidity and microfilaraemia following mass drug administration for lymphatic filariasis in northern Ghana: a cross-sectional study
AU - C. N. Ngmembong
AU - M. Captain-Esoah
AU - S. Lareef
AU - E. D. Angyiereyiri
AU - M. N. Donkor
AU - S. D. Dassah
AU - M. K. Azameti
AU - G. A. Motey
AU - L. A. Adetunde
AU - T. A. Abalori
AU - K. K. Frempong
AU - C. Kubio
AU - V. Asoala
AU - D. A. Boakye
AU - S. K. Dadzie
AU - F. O. Antwi
AU - M. R. Adjei
AU - M. P. Grobusch
AU - D. Bakajika
AU - F. J. Lule
AU - E. Juma
AU - F. Braka
AU - D. Achu
PY - 2026
DA - 2026/10/07
PB - medRxiv
DO - 10.64898/2026.10.07.26364534
UR - https://www.medrxiv.org/content/10.64898/2026.10.07.26364534v1
AB - ObjectivesTo assess microfilaraemia, chronic lymphatic filariasis (LF)-related morbidity, and community knowledge and self-reported preventive behaviours in a rural community in northern Ghana following prolonged mass drug administration (MDA). DesignCommunity-based cross-sectional study. SettingBirifor community, Lawra Municipality, Upper West Region, northern Ghana, from October 2024 to January 2025. ParticipantsA total of 261 community members aged 10 years and above were selected using random sampling and participated in the study. Outcome measuresOutcome measures included microfilaraemia detected by night blood microscopy, chronic LF-related morbidity identified through clinical examination, and community knowledge and self-reported preventive behaviours assessed using a structured questionnaire. ResultsNo microfilariae were detected (0/261; 0%). Chronic lymphoedema was identified in five individuals (1.9%), all aged over 40 years. Awareness of LF was high (95.8%), yet only 39.5% of participants demonstrated good community knowledge and self-reported preventive behaviours. Misconceptions regarding transmission, particularly beliefs that LF is hereditary or caused by spiritual factors, were common. MDA participation was high (93.1%). All five individuals with chronic lymphoedema reported loss of income, and three (60%) reported additional household income loss due to caregiving responsibilities. ConclusionsNo microfilaraemia was detected, suggesting very low transmission in the study area, although residual infection cannot be excluded. Chronic LF-related morbidity and gaps in community knowledge persist despite high MDA participation. Sustained surveillance using more sensitive diagnostic approaches, together with morbidity management and disability prevention, community education and support for affected households, will be important to sustain LF elimination efforts. Article SummaryThis community-based cross-sectional study assessed microfilaraemia, chronic lymphatic filariasis-related morbidity, and community knowledge and self-reported preventive behaviours in a rural community in northern Ghana following prolonged mass drug administration. No microfilariae were detected, suggesting very low transmission, although residual infection could not be excluded. Chronic lymphoedema persisted among a small number of older community members, and important misconceptions regarding disease transmission and prevention remained common despite high awareness and MDA participation. These findings highlight the need for continued surveillance, strengthened morbidity management and disability prevention services, and targeted community education to sustain lymphatic filariasis elimination efforts. Strengths and limitations of this studyO_LIThis study combined parasitological assessment, clinical evaluation of chronic lymphatic filariasis-related morbidity, and assessment of community knowledge and self-reported preventive behaviours within a single community-based survey. C_LIO_LIThe study was conducted in a post-mass drug administration setting, providing evidence relevant to lymphatic filariasis elimination and post-elimination surveillance programmes. C_LIO_LIUse of a participant flow diagram and complete-data analysis improved transparency and reporting of participant recruitment and inclusion. C_LIO_LIThe sample size was below the calculated minimum required for prevalence estimation, limiting the precision of prevalence estimates and the statistical power for multivariable analyses. C_LIO_LIParasitological assessment relied on night blood microscopy because circulating filarial antigen detection and molecular diagnostic methods were not available during fieldwork, limiting detection of low-level residual infection. C_LI
ER -